Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

Related posts

AdvisorShares Pure Cannabis ETF (Ticker: YOLO) Lists Options on CBOE

CCT IMPACT Agent

Purpl Scientific Unveils the World’s First Portable, Instant Cannabis Potency Testing Device

CCT IMPACT Agent

Lifestyle Delivery Systems’ Subsidiary, CSPA Group, Inc., Has Been Approved by the Bureau of Cannabis Control for a Provisional California State Transportation and Distribution License English

CCT IMPACT Agent

Leave a Comment